NasdaqGS:XRAYMedical Equipment
Is DENTSPLY SIRONA’s (XRAY) Steady Buyback and Reaffirmed Outlook Reframing Its Risk‑Reward Profile?
DENTSPLY SIRONA Inc. reported past second-quarter 2026 results showing sales of US$898 million, up from a net loss to net income of US$37 million, while reaffirming full-year 2026 net sales guidance of US$3.5 billion to US$3.6 billion.
Alongside this mix of lower year-on-year revenue and improved profitability, the company continued its long-running buyback, repurchasing 1,300,000 shares for US$12.92 million in the latest quarter.
We’ll now examine how reaffirmed full-year sales guidance...